Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Pap test update.

¹Melbourne Sexual Health Centre, Melbourne, Australia. sheley@vcs.org.au

Australian Family Physician

|March 7, 2007

Summary

This summary is machine-generated.

The Pap test remains crucial for cervical cancer prevention, especially for unvaccinated women. Even vaccinated individuals require ongoing screening due to incomplete HPV type coverage by vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HPV self-sampling and follow-up over two rounds of cervical screening in Australia - the iPap trial.

Journal of medical screening·2022

Same author

Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia.

Gynecologic oncology·2019

Same author

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.

BMJ open·2018

Same author

HAVE YOU HAD THE HPV VACCINE? YOU STILL NEED TO BE SCREENED FOR CERVICAL CANCER.

Australian nursing & midwifery journal·2017

Same author

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.

PLoS medicine·2017

Same author

Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia.

International journal of cancer·2016

Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018

Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018

Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018

Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018

Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018

Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018

See all related articles

Area of Science:

Gynecologic Oncology
Public Health
Vaccinology

Background:

2006 marked significant changes in cervical cancer prevention with new national screening guidelines.
The Australian Government committed to funding the human papillomavirus (HPV) vaccine, Gardasil, under the National Immunisation Program.

Purpose of the Study:

To discuss the role of the cervical screening program and Pap test in light of HPV vaccination.
To address the evolving landscape of cervical cancer prevention strategies.

Main Methods:

Literature review and analysis of current cervical cancer screening protocols.
Discussion of the implications of HPV vaccination on existing screening programs.

Main Results:

Related Experiment Videos

The Pap test remains vital for women who have not been vaccinated against HPV.

Vaccinated populations will still require continued cervical screening, as vaccines do not cover all cancer-causing HPV types.

Conclusions:

The Pap test continues to play a critical role in preventing cervical cancer, particularly for unvaccinated individuals.
Ongoing screening strategies must adapt to incorporate HPV vaccination, acknowledging its limitations in covering all oncogenic HPV types.